In this context, antagonizing miR-145 and the lncRNA DDX11-AS1 [197] can accelerate the HCC progression via the miR-195-5p/MACC1 signaling by binding miR-195-5p which results in elevated MACC1 expression levels. Here, MACC1 is linked to hepatocellular carcinoma.